Indo-MIM IPO Set for Major Listing Debut; Grey Market Premium Signals 36.7% Surge Potential

Indo-MIM IPO Set for Major Listing Debut; Grey Market Premium Signals 36.7% Surge Potential​

Indo-MIM Ltd.'s Rs 3,811-crore initial public offering (IPO) is poised for a significant listing debut on July 30, 2026. The book-built issue is generating intense investor interest, with the Grey Market Premium (GMP) currently indicating a robust market sentiment and potential premium over the issue price.

The IPO involves a fresh issue of 1.03 crore equity shares aggregating to Rs 499.10 crore. This is complemented by an Offer for Sale (OFS) worth Rs 3,311.21 crore from existing shareholders. The total size adds up to the substantial Rs 3,811.21-crore offering.

Indo-MIM IPO GMP: Decoding Market Sentiment​

Ahead of the public subscription opening on July 23, 2026, the stock has seen a strong response in unofficial markets. The Grey Market Premium (GMP) stands at Rs 178. This figure translates into an impressive premium of 36.7% above the upper end of the price band.

Based on this prevailing trend, market speculation suggests that Indo-MIM shares could list at approximately Rs 663 per share, significantly higher than the maximum issue price. Investors are reminded however that GMP is strictly an unofficial indicator of sentiment and does not guarantee the final listing gains.

IPO Timeline and Subscription Details​

The offering is slated to open for subscription on July 23, 2026, with a closing date set for July 27, 2026. The company has established a price band ranging from Rs 461 to Rs 485 per equity share. A minimum lot size of 30 shares is required for investment in the IPO.

The maximum retail investment opportunity, calculated at the upper end of the price band (Rs 485), amounts to Rs 14,550. The basis of allotment is scheduled for July 28, 2026, with the official listing expected on the BSE and NSE on July 30, 2026.

Corporate Profile and Financial Momentum​

Established in 1996, Indo-MIM Ltd. stands as a world leader in precision engineering components using Metal Injection Molding (MIM) technology. The company provides comprehensive end-to-end manufacturing solutions, covering mold design, tooling, machining, finishing, and assembly processes.

Beyond MIM, the organization leverages advanced techniques including investment casting, 3D metal printing, and ceramic injection molding. With its global presence spanning facilities in India, the US, the UK, and Mexico, Indo-MIM claims to possess the world's largest installed MIM capacity as per the F&S Report.

Financial Performance and Future Utilization​

Indo-MIM demonstrated exceptional financial health in FY26. The company successfully grew its total income by 28.1%, reaching Rs 4,320.70 crore from Rs 3,373.97 crore in the previous year (FY25). Profit after tax (PAT) saw a substantial increase of 25.9%, rising to Rs 533.54 crore against Rs 423.73 crore last financial year.

The net proceeds from the fresh issue will be strategically utilized. Indo-MIM plans to allocate Rs 400 crore towards the repayment or prepayment of existing borrowings, ensuring financial stability while the remaining funds are earmarked for general corporate purposes.

Analyst View: Growth Trajectory and Valuation Metrics​

SBI Securities highlights Indo-MIM's strong leadership position in the global MIM industry, noting a market share of 6.8% globally in CY25. The brokerage report details impressive growth figures between FY24 and FY26, showcasing a two-year Compound Annual Growth Rate (CAGR) of 20.9% in revenue.

This sustained performance was also reflected in the industry's productivity metrics, with EBITDA growing at 20.0%. SBI Securities noted that the diversified manufacturing portfolio allows Indo-MIM to efficiently serve crucial sectors like automotive, aerospace, defence, and medical devices, supporting its long-term growth prospects. The IPO is currently valued at 38.4 times FY26 earnings based on the upper price band of Rs 485.